glabridin has been researched along with transforming growth factor beta in 2 studies
| Studies (glabridin) | Trials (glabridin) | Recent Studies (post-2010) (glabridin) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 172 | 4 | 122 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, F; Li, Y; Li, Z; Mu, J; Ning, S; Si, L; Wang, X; Ye, X | 1 |
| Chu, PM; Chueh, PJ; Hsieh, PL; Huang, YF; Lee, PH; Liao, YW; Yang, HW; Yu, CC | 1 |
2 other study(ies) available for glabridin and transforming growth factor beta
| Article | Year |
|---|---|
The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Isoflavones; Liver Neoplasms; MicroRNAs; Neoplastic Stem Cells; Phenols; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2014 |
Glabridin inhibits the activation of myofibroblasts in human fibrotic buccal mucosal fibroblasts through TGF-β/smad signaling.
Topics: Actins; Arecoline; Cell Line; Cell Movement; Collagen Type I; Humans; Isoflavones; Mouth Mucosa; Myofibroblasts; Phenols; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta | 2018 |